XERS - Xeris Pharmaceuticals EPS misses by $0.01 misses on revenue March, 09 2021 07:03 AM Xeris Pharmaceuticals Inc. Xeris Pharmaceuticals (XERS): Q4 GAAP EPS of -$0.41 misses by $0.01.Revenue of $7.09M (+335.0% Y/Y) misses by $1.82M.Press Release For further details see: Xeris Pharmaceuticals EPS misses by $0.01, misses on revenue